Skip to search formSkip to main contentSkip to account menu

Biomarkers, Tumor

Known as: Tumor Marker, Biological, Neoplasm Metabolite Marker, Metabolite Marker, Tumor 
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of… 
National Institutes of Health

Related topics

Related topics

20 relations

Narrower (9)

Adnab-9CA8 protein, humanLGALS3BP protein, humanPHF20 protein, human

Broader (2)

Biological MarkersTumor Markers
In BloodNeoplasm ProteinsProcess of secretionagonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy
AbstractBackground:The standard of care for breast cancer patients with sentinel lymph node (SLN) metastases includes complete… 
Highly Cited
2000
Highly Cited
2000
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.
Highly Cited
2000
Highly Cited
2000
Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.
The blockade of epidermal growth factor receptor (EGFR) function with monoclonal antibodies has major antiproliferative effects… 
Highly Cited
1995
Highly Cited
1995
Clinical Applications of Research on Angiogenesis
Angiogenesis is fundamental to reproduction, development, and repair. All these processes depend on the tightly regulated growth… 
Highly Cited
1993
Highly Cited
1993
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
OBJECTIVE To evaluate the safety and efficacy of a chimeric monoclonal antibody to tumor necrosis factor alpha (TNF alpha) in the… 
Highly Cited
1993
Highly Cited
1993
Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.
Oncogenic transformation by human adenoviruses requires early regions 1A and 1B (E1A and E1B) and provides a model of multistep… 
Highly Cited
1992
Highly Cited
1992
Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.
Tumor necrosis factor alpha (TNF alpha), a primary mediator of systemic responses to sepsis and infection, can be injurious to… 
Highly Cited
1990
Highly Cited
1990
Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells.
A cytokine that can synergize with interleukin 2 to activate cytotoxic lymphocytes was purified to homogeneity. The protein… 
Highly Cited
1989
Highly Cited
1989
Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor
Highly Cited
1987
Highly Cited
1987
Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.
Tumor necrosis factor type alpha (TNF-alpha) inhibits endothelial cell proliferation in vitro. Basal cell growth (in the absence… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)